Improved Contemporary Surgical Management of Insulinomas: A 25-year Experience at the Massachusetts General Hospital
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 39 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine changes in the management strategy of patients with insulinomas and identify critical factors in patient outcome. BACKGROUND: Pancreatic insulinomas are rare neoplasms that are present in various ways. The optimal approach to localization, operative management, and follow-up of insulinomas is undetermined. METHODS: Sixty-one patients with a diagnosis of insulinoma requiring surgery at a tertiary care center between 1983 and 2007 were reviewed. Demographic details, mode of presentation, preoperative localization, operative procedures, and pathology data were assessed. The effect of different factors on survival was determined. RESULTS: Seven of 61 (11%) patients had a diagnosis of multiple endocrine neoplasia-type 1 (MEN-1). Multiple insulinomas were noted in 8% of cases and were more common in MEN-1 patients. The overall rate of malignancy was 8%. Confusion (67%), visual disturbances (42%), and diaphoresis (30%) were the most common presenting symptoms. Weight gain was noted in 44% of patients. The median duration of symptoms before diagnosis was 18 (1-240) months. The sensitivity of preoperative imaging of tumors before 1994 was 75%, compared with 98% after this period, which included use of endoscopic ultrasound scanning (P = 0.012). A combination of palpation and intraoperative ultrasound detected 92% of tumors. Distal pancreatectomy (40%), enucleation (34%), and pancreaticoduodenectomy (16%) were the most common procedures and pancreatic fistula occurred in 18% of patients. Three patients underwent noncurative distal pancreatectomy in the early period. The 10-year disease-specific and disease-free survival was 100% and 90% respectively. There were 5 patients with disease recurrence. Lymph node metastases (P < 0.001), lymphovascular invasion (P < 0.001), and the presence of MEN-1 (P = 0.035) were prognostically significant adverse factors in disease-free survival. Lymphovascular invasion was the only significant factor on multivariate analysis (P = 0.002). CONCLUSION: Pancreatic insulinomas can be readily localized preoperatively with modern imaging to avoid unsuccessful blind pancreatic resection. Surgical resection is associated with low morbidity and mortality and achieves long-term disease-free survival in the absence of lymphovascular invasion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the combination of noninvasive and selected invasive modalities (particularly endoscopic ultrasound), most insulinomas are localized preoperatively (72, 78).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [78]
Citations
Cites
Postoperative pancreatic fistula: An international study group (ISGPF) definition
Bassi, C., Dervenis, C., Butturini, G., Fingerhut, A., Yeo, C., Izbicki, J., Neoptolemos, J., Sarr, M., Traverso, W., & Buchler, M. (2005) · Surgery · doi:10.1016/j.surg.2005.05.001 · Cited by 4,277
Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study.
SERVICE, F. J., McMAHON, M. M., O'BRIEN, P. C., & BALLARD, D. J. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62083-7 · Cited by 883 · cited 5×
“They have a slight predilection for women and most commonly are sporadic, with less than 10% associated with multiple endocrine neoplasia-type 1 (MEN-1).(1,2) Symptoms from insulinoma are related to episodes of hypoglycemia.”
BackgroundResultInfluentialThe Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
KLÖPPEL, G., PERREN, A., & HEITZ, P. U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.002 · Cited by 794
Balcom IV, J. H. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.4.391 · Cited by 769
Self-citationConservation of the Spleen With Distal Pancreatectomy
Warshaw, A. L. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400290032004 · Cited by 614
Self-citationCARCINOMA OF THE ISLANDS OF THE PANCREAS: HYPERINSULINISM AND HYPOGLYCEMIA
WILDER, R. M., ALLAN, F. N., POWER, M. H., & ROBERTSON, H. E. (1927) · Journal of the American Medical Association · doi:10.1001/jama.1927.02690050014007 · Cited by 443
Anderson, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01272-7 · Cited by 399
Hochwald, S. N., Zee, S., Conlon, K. C., Colleoni, R., Louie, O., Brennan, M. F., & Klimstra, D. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.030 · Cited by 397
Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases.
STEFANINI, P., Carboni, M., Patrassi, N., & Basoli, A. (1974) · PubMed · Cited by 296
Service, F. J., Dale, A. J. D., Elveback, L. R., & JIANG, N.-S. (1976) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)07100-9 · Cited by 288
Research works printed but not linked: 1
- Howland, 1929, Dysinsulinism: convulsions and coma due to islet cell tumor of the pancreas with operation and cure., JAMA, 93, 647
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationFrancis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Metz, D. C., & Jensen, R. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.047 · Cited by 816
NANETS Treatment Guidelines: Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Kulke, M. H., Anthony, L. B., Bushnell, D. L., de Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., et al. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb168 · Cited by 574
Sundin, A., Arnold, R., Baudin, E., Cwikla, J. B., Eriksson, B., Fanti, S., Fazio, N., Giammarile, F., Hicks, R. J., Kjaer, A., et al. (2017) · Neuroendocrinology · doi:10.1159/000471879 · Cited by 501
Hackert, T., Hinz, U., Fritz, S., Strobel, O., Schneider, L., Hartwig, W., Büchler, M. W., & Werner, J. (2011) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-011-0801-z · Cited by 182
The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors
Schimmack, S., Svejda, B., Lawrence, B., Kidd, M., & Modlin, I. M. (2011) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-011-0739-1 · Cited by 165
Crippa, S. (2012) · Archives of Surgery · doi:10.1001/archsurg.2011.1843 · Cited by 164
Clinical aspects of multiple endocrine neoplasia type 1
Al‐Salameh, A., Cadiot, G., Calender, A., Goudet, P., & Chanson, P. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00468-3 · Cited by 173
Insulinoma: Pathophysiology, Localization and Management
Shin, J. J., Gorden, P., & Libutti, S. K. (2010) · Future Oncology · doi:10.2217/fon.09.165 · Cited by 161
Surgical management of patients with insulinomas: Result of 292 cases in a single institution
Zhao, Y., Zhan, H., Zhang, T., Cong, L., Dai, M., Liao, Q., & Cai, L. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21773 · Cited by 145
US-guided ethanol ablation of insulinomas: a new treatment option
Levy, M. J., Thompson, G. B., Topazian, M. D., Callstrom, M. R., Grant, C. S., & Vella, A. V. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2011.09.019 · Cited by 135
Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors
Krampitz, G. W., Norton, J. A., Poultsides, G. A., Visser, B. C., Sun, L., & Jensen, R. T. (2012) · Archives of Surgery · doi:10.1001/archsurg.2012.1261 · Cited by 129
Chen, J. W. C., Bhandari, M., Astill, D., Wilson, T. G., Kow, L., Brooke‐Smith, M. E., Toouli, J., & Padbury, R. T. A. (2010) · HPB · doi:10.1111/j.1477-2574.2009.00140.x · Cited by 127
Mathur, A., Gorden, P., & Libutti, S. K. (2009) · Surgical Clinics of North America · doi:10.1016/j.suc.2009.06.009 · Cited by 114
Parenchyma-Sparing Resections for Pancreatic Neuroendocrine Tumors
Cherif, R., Gaujoux, S., Couvelard, A., Dokmak, S., Vuillerme, M.-P., Ruszniewski, P. B., Belghiti, J., & Sauvanet, A. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2002-7 · Cited by 114
Pancreatic Neuroendocrine Tumors
Batcher, E., Madaj, P. M., & Gianoukakis, A. G. (2011) · Endocrine Research · doi:10.3109/07435800.2010.525085 · Cited by 121
Heeger, K., Falconi, M., Partelli, S., Waldmann, J., Crippa, S., Fendrich, V., & Bartsch, D. K. (2014) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-014-1171-0 · Cited by 104
Pancreatic insulinoma: current issues and trends.
Vaidakis, D., Karoubalis, J., Παππά, Θ., Piaditis, G. P., & Zografos, G. N. (2010) · Hepatobiliary & pancreatic diseases international · Cited by 112
Maragliano, R., Vanoli, A., Albarello, L., Milione, M., Baştürk, O., Klimstra, D. S., Wachtel, A. E., Uccella, S., Vicari, E., Milesi, M., et al. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000340 · Cited by 98
James, P. D., Tsolakis, A. V., Zhang, M., Belletrutti, P. J., Mohamed, R., Roberts, D. J., & Heitman, S. J. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.12.031 · Cited by 90
Pieterman, C. R. C., Conemans, E. B., Dreijerink, K. M. A., de Laat, J. M., Timmers, H. T. M., Vriens, M. R., & Valk, G. D. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0482 · Cited by 89
Tsutsumi, K., Ohtsuka, T., Mori, Y., Fujino, M., Yasui, T., Aishima, S., Takahata, S., Nakamura, M., Ito, T., & Tanaka, M. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0540-0 · Cited by 85
Winer, J. H., Choi, H. S., Gibbs‐Strauss, S. L., Ashitate, Y., Colson, Y. L., & Frangioni, J. V. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0868-8 · Cited by 80
Reappraisal of pancreatic enucleations: A single-center experience of 126 procedures
Faitot, F., Gaujoux, S., Barbier, L. A., Novaes, M., Dokmak, S., Aussilhou, B., Couvelard, A., Rebours, V., Ruszniewski, P. B., Belghiti, J., et al. (2015) · Surgery · doi:10.1016/j.surg.2015.03.023 · Cited by 79
Bartsch, D. K., Albers, M. B., Knoop, R. F., Kann, P. H., Fendrich, V., & Waldmann, J. (2013) · Neuroendocrinology · doi:10.1159/000357779 · Cited by 76
Malignant insulinoma: Recommendations for characterisation and treatment
Baudin, E., Caron, P., Lombard-Bohas, C., Tabarin, A., Mitry, E., Reznick, Y., Taieb, D., Pattou, F., Goudet, P., Vezzosi, D., et al. (2013) · Annales d'Endocrinologie · doi:10.1016/j.ando.2013.07.001 · Cited by 67
Birnbaum, D. J., Gaujoux, S., Cherif, R., Dokmak, S., Fuks, D., Couvelard, A., Vullierme, M., Ronot, M., Ruszniewski, P. B., Belghiti, J., et al. (2013) · Surgery · doi:10.1016/j.surg.2013.08.007 · Cited by 67
Hackeng, W. M., Schelhaas, W., Morsink, F. H. M., Heidsma, C. M., van Eeden, S., Valk, G. D., Vriens, M. R., Heaphy, C. M., van Dijkum, E. J. M. N., Offerhaus, G. J. A., et al. (2020) · Endocrine Pathology · doi:10.1007/s12022-020-09611-8 · Cited by 67
Worhunsky, D. J., Krampitz, G. W., Poullos, P. D., Visser, B. C., Kunz, P. L., Fisher, G. A., Norton, J. A., & Poultsides, G. A. (2013) · HPB · doi:10.1111/hpb.12139 · Cited by 65
Pancreatic neuroendocrine tumors
Krampitz, G. W., & Norton, J. A. (2013) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2013.08.001 · Cited by 64
Sakurai, A., Yamazaki, M., Suzuki, S., Fukushima, T., Imai, T., Kikumori, T., Okamoto, T., Horiuchi, K., Uchino, S., Kosugi, S., et al. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0173 · Cited by 57
Comparison of benign and malignant insulinoma
Sada, A., Yamashita, T. S., Glasgow, A. E., Habermann, E. B., Thompson, G. B., Lyden, M. L., Dy, B. M., Halfdanarson, T. R., Vella, A. V., & McKenzie, T. J. (2020) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2020.08.003 · Cited by 56
Surgical Management of Pancreatic Neuroendocrine Tumors
Sulciner, M. L., & Clancy, T. E. (2023) · Cancers · doi:10.3390/cancers15072006 · Cited by 54
Neuroendocrine tumors of the pancreas
Davies, K., & Conlon, K. C. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0019-1 · Cited by 54
Current Management of the Zollinger-Ellison Syndrome
Krampitz, G. W., & Norton, J. A. (2013) · Advances in Surgery · doi:10.1016/j.yasu.2013.02.004 · Cited by 53
What should be done in an operating room when an insulinoma cannot be found?
Rostambeigi, N., & Thompson, G. B. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03527.x · Cited by 53
Vezzosi, D., Cardot-Bauters, C., Bouscaren, N., Bras, M. L., Bertholon-Grégoire, M., Niccoli, P., Lévy-Bohbot, N., Groussin, L., Bouchard, P., Tabarin, A., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0878 · Cited by 52
Melita, G., Pallio, S., Tortora, A., Crinò, S. F., Macrì, A., & Dionigi, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122638 · Cited by 52
The treatment of hyperinsulinemic hypoglycaemia in adults: an update
On behalf of NIKE Group, Davi′, M. V., Pia, A., Guarnotta, V., Pizza, G., Colao, A., & Faggiano, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0536-3 · Cited by 51
The Incidence and Survival of Rare Cancers of the Thyroid, Parathyroid, Adrenal, and Pancreas
James, B. C., Aschebrook‐Kilfoy, B., Cipriani, N. A., Kaplan, E. L., Angelos, P., & Grogan, R. H. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4901-9 · Cited by 50
The surgical management of insulinomas in children
Peranteau, W. H., Palladino, A., Bhatti, T. R., Becker, S. A., States, L. J., Stanley, C. A., & Adzick, N. S. (2013) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2013.04.022 · Cited by 52
Molecular imaging in the investigation of hypoglycaemic syndromes and their management.
Pattison, D., & Hicks, R. (2017) · Endocrine-Related Cancer · doi:10.1530/erc-17-0005 · Cited by 43
Goh, B. K. P., Ooi, L. L., Cheow, P. C., Tan, Y., Ong, H. S., Chung, Y. F. A., Chow, P. K. H., Wong, W., & Soo, K. C. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-0858-y · Cited by 47
Law, J. K., Singh, V. K., Khashab, M. A., Hruban, R. H., Canto, M. I., Shin, E. J., Saxena, P., Weiss, M. J., Pawlik, T. M., Wolfgang, C. L., et al. (2013) · Surgical Endoscopy · doi:10.1007/s00464-013-2975-7 · Cited by 47
Malignant Insulinoma: A Rare Form of Neuroendocrine Tumor
Sada, A., Glasgow, A. E., Vella, A. V., Thompson, G. B., McKenzie, T. J., & Habermann, E. B. (2020) · World Journal of Surgery · doi:10.1007/s00268-020-05445-x · Cited by 47
Surgery and Staging of Pancreatic Neuroendocrine Tumors: A 14-Year Experience
Ito, H., Abramson, M. J., Ito, K., Swanson, E. W., Cho, N., Ruan, D. T., Swanson, R. S., & Whang, E. E. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1173-3 · Cited by 45
Paiella, S., Pastena, M. D., Landoni, L., Esposito, A., Casetti, L., Miotto, M., Ramera, M., Salvia, R., Secchettin, E., Bonamini, D., et al. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5501-5 · Cited by 44
Peltola, E., Hannula, P. M., Huhtala, H., Metso, S., Kiviniemi, U., Vornanen, M., Sand, J. A., Laukkarinen, J., Tiikkainen, M., Schalin‐Jäntti, C., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/2059481 · Cited by 44
Surgical management of pancreatic neuroendocrine tumors
Kimura, W., Tezuka, K., & Hirai, I. (2011) · Surgery Today · doi:10.1007/s00595-011-4547-6 · Cited by 44
Insulinoma After Bariatric Surgery: Diagnostic Dilemma and Therapeutic Approaches
Mulla, C. M., Storino, A., Yee, E. U., Lautz, D., Sawnhey, M. S., Moser, A. J., & Patti, M.-E. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2092-5 · Cited by 40
Endocrine neoplasms in familial syndromes of hyperparathyroidism
Li, Y., & Simonds, W. F. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0059 · Cited by 41
Surgical Management of Neuroendocrine Tumours of the Pancreas
Souche, F.-R., Hobeika, C., Hain, É., & Gaujoux, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092993 · Cited by 38
Heaphy, C. M., & Singhi, A. D. (2022) · Human Pathology · doi:10.1016/j.humpath.2022.07.015 · Cited by 36
Management of malignant insulinoma
Ferrer-García, J. C., Iranzo, V., de Solís, S. N., Civera-Andrés, M., Morillas, C., Alfaro, A. Á. M., Caballero-Díaz, C., Sánchez-Juan, C., & Camps, C. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0996-7 · Cited by 34
Furnica, R. M., Deprez, P. H., Maiter, D. M., Vandeleene, B., & Borbath, I. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.11.009 · Cited by 34
When should genetic testing be performed in patients with neuroendocrine tumours?
O’Shea, T., & Druce, M. R. (2017) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9430-3 · Cited by 34
Open and minimally invasive pancreatic neoplasms enucleation: a systematic review
Valle, R. D., Cremaschi, E., Lamecchi, L., Guerini, F., Rosso, E., & Iaria, M. (2019) · Surgical Endoscopy · doi:10.1007/s00464-019-06967-9 · Cited by 31
Surgical management of pancreatic neuroendocrine tumors: an introduction
Hain, É., Sindayigaya, R., Fawaz, J., Gharios, J., Bouteloup, G., Soyer, P. A., Bertherat, J. Y., Prat, F., Terris, B., Coriat, R., et al. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1703677 · Cited by 30
Long-term morbidity and mortality in patients diagnosed with an insulinoma
Peltola, E., Hannula, P. M., Huhtala, H., Metso, S., Sand, J. A., Laukkarinen, J., Tiikkainen, M., Sirén, J., Soinio, M., Nuutila, P., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0230 · Cited by 33
Zhu, L., Xue, H., Sun, H., Wang, X., He, Y., Jin, Z., & Zhao, Y.-P. (2016) · European Radiology · doi:10.1007/s00330-016-4216-7 · Cited by 31
A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series
Yu, R., Nissen, N. N., Hendifar, A., Tang, L. A., Song, Y., Chen, Y., & Fan, X. (2016) · Pancreas · doi:10.1097/mpa.0000000000000718 · Cited by 29
Risk factors for the occurrence of insulinoma: a case-control study
Zhan, H., Cong, L., Zhao, Y.-P., Zhang, T., & Chen, G. (2013) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(13)60051-x · Cited by 26
Robotic enucleation for pediatric insulinoma with MEN1 syndrome: a case report and literature review
Liang, M., Jiang, J., Dai, H., Hong, X., Han, X., Cong, L., Tong, A., Li, F., Luo, Y., Liu, W., et al. (2018) · BMC Surgery · doi:10.1186/s12893-018-0376-5 · Cited by 26
REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY
Lynch, J. P., Metz, D. C., Schuppan, D., Junker, Y., & Barisani, D. (2009) · Cited by 24
Surgical Management of Pancreatic Neuroendocrine Tumors
Chiruvella, A., & Kooby, D. A. (2016) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.12.002 · Cited by 26
Endocrine Tumors of the Pancreas and Gastrointestinal Tract
Jensen, R. T., & Norton, J. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00032-9 · Cited by 28
Laparoscopic Resection of Pancreatic Tumors in Children: Results of a Multicentric Survey
Esposito, C., Lagausie, P. P. D., Escolino, M., Saxena, A. K., Holcomb, G. W., III, Settimi, A., Becmeur, F., & van der Zee, D. C. (2017) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2016.0630 · Cited by 24
Preoperative Localisation and Surgical Management of Insulinoma: Single Centre Experience
Varma, V., Tariciotti, L., Coldham, C., Taniere, P., Buckels, J. A. C., & Bramhall, S. R. (2011) · Digestive Surgery · doi:10.1159/000322405 · Cited by 23
Multiple Endocrine Neoplasia Type 1: Clinical Manifestations and Management
Powell, A. C., & Libutti, S. K. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0857-5_16 · Cited by 23
Filip, K., Lewińska, A., Adamczyk‐Grochala, J., Marino, A., Cappello, F., Lauricella, M., & Wnuk, M. (2022) · Cells · doi:10.3390/cells11071213 · Cited by 24
The future: surgical advances in MEN1 therapeutic approaches and management strategies
Sadowski, S. M., Cadiot, G., Dansin, É., Goudet, P., & Triponez, F. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0285 · Cited by 23
Laparoscopic surgery for pancreatic insulinomas: an update
Aggeli, C., Nixon, A. M., Karoumpalis, I., Kaltsas, G., & Zografos, G. N. (2016) · HORMONES · doi:10.14310/horm.2002.1670 · Cited by 22
Solid Tumors of the Body and Tail of the Pancreas
Morgan, K. A., & Adams, D. B. (2010) · Surgical Clinics of North America · doi:10.1016/j.suc.2009.12.009 · Cited by 23
Hines, O. J., & Reber, H. A. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32830b112e · Cited by 20
Gastroenteropancreatic neuroendocrine tumors: Role of surgery
Sauvanet, A. (2019) · Annales d Endocrinologie · doi:10.1016/j.ando.2019.04.009 · Cited by 19
Insulinoma case series: Experience of a tertiary care center
Kalra, P., Anakal, M., Dharmalingam, M., Indushekhar, S., Rao, V., & KUMAR, K. M. P. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.141385 · Cited by 19
Activated mTOR/P70S6K Signaling Pathway Is Involved in Insulinoma Tumorigenesis
Zhan, H., Cong, L., Zhao, Y., Zhang, T., Chen, G., Zhou, L., & Guo, J. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23176 · Cited by 18
“Insulinoma is the most common functional neuroendocrine tumor of pancreas, accounting for 70–80% of all pancreatic neuroendocrine tumors [1–3].”
BackgroundMechanism and recent updates on insulin-related disorders
Kumar, S., Senapati, S., Bhattacharya, N., Bhattacharya, A., Maurya, S. K., Husain, H., Bhatti, J. S., & Pandey, A. K. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i25.5840 · Cited by 21
Teres Hepatis Ligament Flap Plasty to Prevent Pancreatic Fistula after Tumor Enucleation
Hackert, T., Lozanovski, V. J., Werner, J., Büchler, M. W., & Schemmer, P. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2013.06.014 · Cited by 17
Insulinoma and anaesthetic implications
Goswami, J., Somkuwar, P., & Naik, Y. (2012) · Indian Journal of Anaesthesia · doi:10.4103/0019-5049.96301 · Cited by 17
Malignant insulinoma arising from intrasplenic heterotopic pancreas.
Cárdenas, C. M. H., Domínguez, I., Campuzano, M., Bezaury, P., Iñiguez-Rodríguez, M., Gamboa‐Domínguez, A., & Uscanga, L. F. (2009) · PubMed · Cited by 17
Surgical management of neuroendocrine tumors of the gastrointestinal tract.
Huang, L. C., Poultsides, G. A., & Norton, J. A. (2011) · PubMed · Cited by 16
Leelasinjaroen, P., Manatsathit, W., Berri, R., Barawi, M., & Gress, F. G. (2014) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v6.i10.506 · Cited by 16
Recommandations pour la prise en charge de l’insulinome malin
Baudin, É., Caron, P. J., Lombard‐Bohas, C., Tabarin, A., Mitry, E., Reznick, Y., Taïeb, D., Pattou, F. N., Goudet, P., Vezzosi, D., et al. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2013.08.007 · Cited by 15
de Ponthaud, C., Ménégaux, F., & Gaujoux, S. (2021) · Cancers · doi:10.3390/cancers13235969 · Cited by 15
Couvelard, A., & Sauvanet, A. (2008) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-008-0678-6 · Cited by 14
Hypoglycemia in the toddler and child
Langdon, D. R., Stanley, C. A., & Sperling, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00030-5 · Cited by 15
De Sousa, S. M. C., Haghighi, K. S., Qiu, M. R., Greenfield, J. R., & Chen, D. L. T. (2016) · Pancreas · doi:10.1097/mpa.0000000000000430 · Cited by 13
Nakamura, Y., Matsushita, A., Katsuno, A., Yamahatsu, K., Sumiyoshi, H., Mizuguchi, Y., & Uchida, E. (2015) · Asian Journal of Endoscopic Surgery · doi:10.1111/ases.12187 · Cited by 14
Senica, K., Tomažič, A., Skvarča, A., Peitl, P. K., Mikołajczak, R., Hubalewska–Dydejczyk, A., & Ležaić, L. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01372-z · Cited by 13
Kumar, S., Melek, M., & Rohl, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.906012 · Cited by 13
Zhao, Y.-P., Zhan, H., Cong, L., Zhang, T., Liao, Q., Dai, M., Cai, L., & Zhu, Y. (2012) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(11)60132-x · Cited by 12
T372R Mutation Status in Yin Yang 1 Gene in Insulinoma Patients
Irshad, K., Jyotsna, V. P., Agarwal, S., Chosdol, K., Pal, S., & Deepak, R. K. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-107244 · Cited by 12
Nakano, Y., Kitago, M., Shinoda, M., Nakatsuka, S., Kurihara, I., Yagi, H., Abe, Y., Oshima, G., Hori, S., Yokose, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80538-0 · Cited by 11
Ectopic insulinoma: a systematic review
Guerrero‐Pérez, F., Vilarrasa, N., Huánuco, L. V., Busquets, J., Secanella, L., Vercher-Conejero, J. L., Vidal, N., Näf, S., & Villabona, C. M. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09824-2 · Cited by 12
Recurrent hypoglycaemia in a type 2 diabetes patient – diagnostic difficulties
Grycewicz, J., Ścibór, Z., Ćwikła, J. B., Lewiñski, A., & Cypryk, K. (2010) · Archives of Medical Science · doi:10.5114/aoms.2010.13520 · Cited by 12
Gao, H., Wang, W., Xu, H., Wu, C., Jin, W., Zhang, S., Xu, J., Ni, Q., Yu, X., & Liu, L. (2019) · Pancreatology · doi:10.1016/j.pan.2019.02.011 · Cited by 10
Metadata
- Authors
- Nikfarjam, M., Warshaw, A. L., Axelrod, L., Deshpande, V., Thayer, S. P., Ferrone, C. R., & Fernández-del Castillo, C.
- Affiliations
- Harvard University (US)
- Nebraska Medical Center (US)
- Corresponding author
- Nikfarjam, Mehrdad
- Warshaw, Andrew L.
- Thayer, Sarah P.
- Ferrone, Cristina R.
- Venue
- Annals of Surgery
- Published
- 2008-01
- Volume
- 247
- Issue
- 1
- Pages
- 165-172
- ISSN
- 0003-4932 (ISSN-L)
- PMC
- PMC3806046
- OpenAlex
- W1999848832
- Cited by
- 221
- References
- 41
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 13 · 2019: 9 · 2018: 6 · 2017: 18 · 2016: 8 · 2015: 15 · 2014: 18 · 2013: 19 · 2012: 22
- FWCI
- 10.39
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Annals of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P01CA117969)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- insulinoma, pancreatic neuroendocrine tumors, multiple endocrine neoplasia type 1, preoperative tumor localization, endoscopic ultrasound, intraoperative ultrasound, distal pancreatectomy, pancreaticoduodenectomy, pancreatic enucleation, pancreatic fistula, lymphovascular invasion, lymph node metastasis, disease-free survival, prognostic factors, tumor recurrence, surgical resection
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Humans, Insulinoma, Male, Massachusetts, Middle Aged, Neoplasm Recurrence, Local, Pancreatic Neoplasms, Postoperative Complications, Prognosis, Prospective Studies, Survival Rate, Chi-Square Distribution, Proportional Hazards Models, Treatment Outcome, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.